Study pits two Vision-Saving injections against each other
NCT ID NCT06850571
Summary
This study aims to compare two different eye injections used to treat vision loss from diabetic eye disease. Researchers in Iraq will test which medicine (aflibercept or bevacizumab) works better at improving vision and reducing swelling in the back of the eye. They will also compare the cost and safety of the two treatments in 102 patients who will receive three monthly injections.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC MACULOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baghdad Medical City Complex
RECRUITINGBaghdad, 10001, Iraq
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.